EFTA01392588.pdf

DataSet-10 1 page 279 words document
P21
👁 1 💬 0
📄 Extracted Text (279 words)
GLOUS1 28 Patrick Gerschel SOF IV - Master Fund Key Terms Same key terms as SOF III with an increased team commitment The Fund Glendower Capital Secondary Opportunities Fund IV, LP Target Size USS1.75 billion (US$2.5 billion hard cap) Structure English private fund limited partnership Investment Period 4 years from final closing 7 years from final closing plus up to 5 one-year extensions (the first three one-year extensions being at the discretion of Term Glendower and the final two one-year extensions requiring the consent of the SOF IV advisory committee) Minimum Commitment USS5 million Team Commitment Min of 1% of aggregate commitments 1.25% p.a. of commitments during Investment Period General Partner Share 1.00% p.a. of Invested Capital' for a period of 2 years after the Investment Period, thereafter greater of 90% of previous year and 0.25% Carried Interest 12.5% on a whole fund basis Hurdle Rate 8% (with 100% catch-up) Clawback Yes Peave read the coniklent-A private 8ra:err:Atm memorandum of the Fin) tale Meitiorarylorril or the kill dsdostre of risk far tors. conflicts of imerest, canyktte terms, arki regulatory and tav considerations of the Fund. For hither draitiosure of fees, such as lees and Lt4%enses paid by the Fund, please refer to the Memorandum, the amended and restated limited partnership agreement and the deed of adherence of d r..». 1 ." dootanents are in the process of being prepared and will be made available to prospectrw investors upon retf,rest. 1) Invested Capital is the amount of capital invested in investments and the remaining unhanded obligations reasonably reserved by Glendower for such investments. Glendower STRICTLY CONFIDENTIAL Capital CONFIDENTIAL - PURSUANT TO FED. R CRIM. P. 6(e) DB-SDNY-0097836 CONFIDENTIAL SDNY_GM_00244020 EFTA01392588
ℹ️ Document Details
SHA-256
f388def800816084e12ecf534ff86fdd47cf99e41344387c1482deac63be63ca
Bates Number
EFTA01392588
Dataset
DataSet-10
Type
document
Pages
1

Community Rating

Sign in to rate this document

📋 What Is This?

Loading…
Sign in to add a description

💬 Comments 0

Sign in to join the discussion
Loading comments…
Link copied!